Clinical Microbiology: From Specimen Collection to Pathogen Identification

Clinical microbiology is the diagnostic discipline that connects patient care with laboratory science through a structured workflow beginning at specimen collection and ending with pathogen identification and antimicrobial susceptibility testing. The accuracy of every downstream result depends on decisions made before the specimen reaches the laboratory bench. This article explains the complete diagnostic pathway for laboratory students, technicians, researchers, and diagnostic professionals, with emphasis on practical workflow decisions, quality controls, and interpretation limits.

The Diagnostic Chain and Why Pre-Analytical Quality Determines Outcome

The microbiological diagnostic process is a chain of linked steps where failure at any point compromises the final result. The interpretation and accuracy of microbiological results depend to a great extent on the quality of the samples and their processing within the microbiology laboratory. The type of specimen, the appropriate time to obtain the sample, the way of sampling, the storage and transport are critical points in the diagnostic process. When a specimen is collected improperly, transported under unsuitable conditions, or processed after excessive delay, even the most sophisticated identification platform cannot recover the lost information.

Laboratory automation and rapid techniques now allow the precision and turnaround time necessary to help clinicians in decision making. However, to be efficient, it is very important to obtain clinical information to use the best diagnostic tools. The laboratory must know the suspected diagnosis, the patient's clinical context, and the antimicrobial history to select appropriate culture media, incubation conditions, and identification pathways. Without this clinical context, the laboratory may miss fastidious organisms, misinterpret contaminants, or delay critical results.

The World Health Organization Laboratory Quality Management System Handbook provides the framework for ensuring that each step in this chain meets defined quality standards. Laboratories that implement documented procedures for collection, transport, processing, and reporting reduce variability and improve patient outcomes.

At a Glance: Specimen Types and Recommended Culture Media

The selection of culture media depends on the specimen source, the suspected pathogens, and the normal flora expected at that body site. The table below summarizes common specimen types, their associated clinical questions, and appropriate primary culture media.

For respiratory samples from people with cystic fibrosis, non-selective and selective culture media are recommended for all types of respiratory samples, including samples obtained after lung transplantation. This approach optimizes detection of Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, and Burkholderia cepacia complex, as well as less common non-lactose fermenting Gram-negative bacilli such as Stenotrophomonas maltophilia, Inquilinus, Achromobacter, Ralstonia, and Pandoraea species, and yeasts and filamentous fungi.

Specimen Collection Principles

Timing and Collection Before Antimicrobial Therapy

The appropriate time to obtain the sample is a critical point in the diagnostic process. Specimens should be collected during the acute phase of illness when the pathogen burden is highest. For blood cultures, collection should occur before antimicrobial therapy begins whenever clinically feasible. Once antimicrobials are administered, organism viability declines rapidly and culture yield drops substantially.

For urine specimens, the first morning void provides the most concentrated sample and the best opportunity for pathogen detection. For respiratory specimens, sputum collected on waking represents lower respiratory secretions instead of saliva. For wound specimens, collection should occur before antiseptic application to the site.

Collection Technique by Specimen Type

Proper collection technique minimizes contamination by normal flora and ensures that the specimen represents the infected site. For midstream urine, the patient should clean the urethral area, begin voiding, and collect the middle portion of the stream. For blood cultures, the venipuncture site requires antiseptic preparation with an appropriate disinfectant and the bottles require inoculation to the indicated fill volume.

For respiratory samples from people with cystic fibrosis, the collection of sputum samples has decreased while the collection of other types of respiratory samples such as oropharyngeal and bronchoalveolar lavage samples has increased. This shift reflects improved patient health from CF transmembrane conductance regulator modulator therapy, which means fewer patients spontaneously expectorate sputum. Laboratories must adapt their processing protocols to handle these alternative sample types.

For catheter-related bloodstream infection, the diagnosis may require paired blood cultures drawn through the catheter and from a peripheral venipuncture. Catheter-related bloodstream infections constitute an important cause of hospital-acquired infection associated with morbidity, mortality, and cost. The clinical guidelines from the Spanish Society of Infectious Diseases and Clinical Microbiology and the Spanish Society of Intensive and Critical Care Medicine and Coronary Units establish the clinical situations in which a conservative diagnosis of catheter-related bloodstream infection without catheter removal is feasible.

Specimen Containers and Labeling

Every specimen container must be sterile, leak-proof, and appropriate for the specimen type. The container must be labeled with at least two patient identifiers, the collection date and time, the specimen source, and the requesting clinician. Unlabeled or mislabeled specimens should be rejected and recollected. The laboratory should document the rejection criteria and communicate them to clinical staff.

The World Health Organization Laboratory Quality Management System Handbook emphasizes that specimen labeling errors can lead to misidentification of patients and incorrect clinical decisions. Laboratories should implement barcode-based identification systems where available to reduce transcription errors.

Transport and Storage Conditions

Transport Media and Timing

The storage and transport of specimens are critical points in the diagnostic process. Different pathogens have different viability requirements. Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae are fastidious and die rapidly at room temperature or when refrigerated. Anaerobic bacteria require oxygen-free conditions. Viruses require appropriate viral transport media.

For stool specimens, transport in Cary-Blair medium preserves enteric pathogens when processing is delayed. For wound specimens, swabs should be placed in appropriate transport medium such as Amies medium. For respiratory specimens, processing should occur within two hours of collection or the specimen should be refrigerated if delay is unavoidable.

Microbiology specimens are unique among clinical specimens in that optimal analysis may require the maintenance of viable organisms. Centralized laboratories may be located hours from patient care settings, and transport conditions need to be such that organism viability can be maintained under a variety of transport conditions. This is particularly relevant for laboratories that serve multiple hospitals or remote collection sites.

Temperature Requirements

The temperature during transport varies by specimen type. Cerebrospinal fluid should be transported at room temperature and processed immediately. Urine specimens should be processed within two hours or refrigerated to prevent overgrowth of contaminating organisms. Blood culture bottles should be transported at room temperature and placed in the incubator promptly.

For mycobacterial specimens, the review of specimen collection and shipment emphasizes that proper handling preserves organism viability for culture and molecular testing. Mycobacterial specimens are less fastidious than many bacteria but still require appropriate transport conditions to maintain diagnostic yield.

Transport to Centralized Laboratories

The consolidation of clinical microbiology laboratories has created new challenges for specimen transport. Centralized laboratories may be located hours from patient care settings, and transport conditions need to be such that organism viability can be maintained under a variety of transport conditions. Since the provision of rapid results has been shown to enhance patient care, effective and timely means for generating and then reporting the results of clinical microbiology analyses must be in place.

Laboratories serving multiple hospitals must establish transport schedules that minimize delay, validate transport containers for temperature stability, and train couriers in proper specimen handling. The point-counterpoint discussion on consolidated clinical microbiology laboratories notes that infectious disease specialists are more dependent than ever on access to high-quality diagnostic information from clinical microbiology laboratories.

Specimen Processing and Culture Setup

Specimen Acceptance and Rejection Criteria

The laboratory must have documented criteria for specimen acceptance and rejection. These criteria include proper labeling, appropriate container, correct transport medium, and acceptable time from collection to receipt. Specimens that do not meet these criteria should be rejected and the clinical team notified for recollection.

The World Health Organization Laboratory Quality Management System Handbook provides guidance on developing acceptance and rejection policies. The laboratory should track rejection rates by collection site and provide feedback to improve collection practices.

Culture Media Selection

The selection of culture media follows the specimen type and the suspected pathogens. Blood agar supports the growth of most medically important bacteria. Chocolate agar provides factors required by fastidious organisms such as Haemophilus species and Neisseria species. MacConkey agar selects for Gram-negative bacilli and differentiates lactose fermenters. Selective media inhibit normal flora and enhance recovery of specific pathogens.

For respiratory samples from people with cystic fibrosis, the guidance recommends non-selective and selective culture media for all types of respiratory samples. This approach detects the range of pathogens that colonize and infect this patient population, including Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, Burkholderia cepacia complex, Stenotrophomonas maltophilia, Inquilinus, Achromobacter, Ralstonia, and Pandoraea species, and yeasts and filamentous fungi.

For Acinetobacter species, specimen collection, processing, culture, and biochemical identification require specific media and incubation conditions. Acinetobacter species are non-fermenting Gram-negative coccobacilli that grow on standard media but require careful biochemical testing for species-level identification.

Incubation Conditions

Incubation conditions vary by specimen type and suspected pathogen. Standard bacterial cultures incubate at 35 to 37 degrees Celsius in ambient air or with increased carbon dioxide. Anaerobic cultures require oxygen-free environments. Mycobacterial cultures require extended incubation periods of several weeks.

The expected turnaround time for laboratory reports varies by method. The mycobacteriology laboratory review emphasizes the expected turnaround time for the various laboratory reports from different methods and the potential of new methods to expedite laboratory results.

Pathogen Identification Methods

Conventional Biochemical Identification

Conventional biochemical tests identify bacteria based on their metabolic characteristics. These tests include catalase, oxidase, coagulase, and sugar fermentation reactions. Commercial identification panels combine multiple biochemical tests in a single format and provide probabilistic identification based on reaction patterns.

For Acinetobacter species, biochemical identification follows culture and requires differentiation from other non-fermenting Gram-negative bacilli. The Methods in Molecular Biology chapter on specimen collection, processing, culture, and biochemical identification of Acinetobacter species provides the technical details for this workflow.

Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has transformed pathogen identification in clinical microbiology. This technology generates a protein mass spectrum from intact bacterial cells and compares it to a reference database for species identification.

The VITEK MS Research Use Only database offers broader species coverage than the approved in vitro diagnostic database, yet its clinical adoption is hindered by insufficient performance validation and inefficient manual operational workflows. A dual-phase strategy to integrate the VITEK MS RUO database into routine clinical practice demonstrated high concordance between the RUO and IVD databases, with the RUO database providing valid supplementary identification for cases where the IVD database failed. The integrated workflow increased the overall identification rate and reduced reanalysis turnaround time by more than 75 percent.

Molecular Identification Methods

Molecular methods detect pathogen nucleic acid directly from clinical specimens or from cultured isolates. Polymerase chain reaction (PCR) amplifies specific DNA targets and provides sensitive and specific detection. Real-time PCR quantifies the target during amplification. Syndromic panels test for multiple pathogens simultaneously from a single specimen.

The QIAstat-Dx meningitis-encephalitis syndromic test kit was evaluated against the conventional diagnostic microbiology workflow in a multicenter study. The syndromic panel detected viral targets, bacterial targets, and Cryptococcus neoformans targets in cerebrospinal fluid samples. The study noted discrepant results for samples with high cycle threshold values, indicating low pathogen burden, and recommended confirmation of low-positive results with alternative methods.

For SARS-CoV-2 detection, the review of tools and techniques emphasizes the importance of the timing and type of specimen collection, along with factors such as disease prevalence, setting, and methods. Molecular, antigen-based, and immunological point-of-care testing each have defined roles in the diagnostic algorithm.

Antimicrobial Susceptibility Testing

Antimicrobial susceptibility testing determines which antimicrobial agents are effective against the isolated pathogen. The reference method is broth microdilution, which provides quantitative minimum inhibitory concentration values. Disk diffusion and gradient diffusion methods provide qualitative or semi-quantitative results.

EUCAST rapid antimicrobial susceptibility testing (RAST) provides results directly from positive blood cultures, reducing the time to actionable susceptibility data. A combined workflow using RAST with lateral flow immunochromatographic assays for resistance detection demonstrated high categorical agreement with definitive susceptibility testing and enabled appropriate antimicrobial therapy modification in a majority of patients.

For carbapenemase-producing Enterobacterales, particularly OXA-48-producing isolates, rapid confirmation of carbapenemase production is essential to optimize antimicrobial therapy and infection control measures. The simplified carbapenem inactivation method eliminates the preliminary carbapenem inactivation incubation step, simplifying the workflow and reducing turnaround time. This method detected all OXA-48-producing Enterobacterales with high sensitivity, including isolates with low ertapenem minimum inhibitory concentrations.

Laboratory Automation in Clinical Microbiology

Total Laboratory Automation for Culture Processing

Historically, the trend toward automation in clinical pathology laboratories has largely bypassed the clinical microbiology laboratory. However, the review of automation in clinical microbiology describes the currently available specimen-processing instruments and total laboratory automation solutions, and outlines the types of studies needed to assess their benefits.

Total laboratory automation for urine culture processing has been evaluated in multiple studies. A comparison of total laboratory automation with manual processing in urine culture inoculation and interpretation found that automation reduced setup time by 79 to 83 percent and total staff time by 77 to 78 percent. Manual processing showed greater operator-dependent variability, which automation substantially reduced. Colony-forming unit recovery was concordant in high-burden specimens, with method-dependent differences in routine diagnostic samples.

A health technology assessment of total laboratory automation for microbiology activities found significant reductions in sample processing times, including a 67 percent decrease in check-in time and significant reductions in inoculation and plate reading times. Economic analysis indicated a 67 percent reduction in costs for personnel time required to process urine cultures and perform initial workups of positive blood cultures.

A comparative study of urine culture turnaround time before and after total laboratory automation implementation found that automation significantly reduced median turnaround time for both negative and positive cultures. Variability in reporting times decreased, indicating improved consistency. Laboratory productivity increased more than threefold.

Automation for Identification and Susceptibility Testing

Automation extends beyond culture processing to identification and susceptibility testing. Automated identification systems use biochemical reactions, mass spectrometry, or molecular methods. Automated susceptibility testing systems provide quantitative results with reduced hands-on time.

The integrated workflow for MALDI-TOF MS identification with automated RUO database reanalysis demonstrates how automation can enhance laboratory efficiency while maintaining compliance. The automated software reduced reanalysis turnaround time by more than 75 percent, saving consumables and labor.

Implementation Considerations for Automation

Laboratories considering automation must evaluate the capital investment, operational costs, and expected benefits. The health technology assessment approach integrates real-life data, key performance indicators, and healthcare professionals' perceptions. Automation should be implemented in phases, with validation of each workflow change before full deployment.

The review of automation in clinical microbiology notes that studies will need to be performed to fully assess the benefits of automation in microbiology laboratories. Laboratories should document their own data on turnaround time, error rates, and staff time before and after automation implementation.

Quality Control and Quality Assurance

Internal Quality Control

Internal quality control monitors the day-to-day performance of laboratory procedures. Culture media should be tested with control organisms to verify growth support and selectivity. Identification systems should be tested with known organisms to verify database accuracy. Susceptibility testing should be performed with reference strains to verify method performance.

The World Health Organization Laboratory Quality Management System Handbook provides the framework for developing an internal quality control program. The laboratory should document quality control results, investigate failures, and implement corrective actions.

External Quality Assessment

External quality assessment programs provide specimens of unknown content to laboratories for testing. The laboratory results are compared to reference results to assess accuracy. Participation in external quality assessment is a requirement for laboratory accreditation in many jurisdictions.

The QIAstat-Dx meningitis-encephalitis evaluation included testing of an external quality assessment panel consisting of ten samples. The syndromic panel achieved 100 percent concordance in testing a blinded bacterial meningitis-encephalitis external quality assessment panel.

Method Validation and Verification

Method validation establishes that a new method performs as expected in the laboratory setting. The U.S. Food and Drug Administration Bioanalytical Method Validation Guidance provides the framework for validating analytical methods, including accuracy, precision, selectivity, sensitivity, and reproducibility. The Assay Guidance Manual from the National Center for Advancing Translational Sciences provides additional technical guidance for assay development and validation.

For the VITEK MS RUO database integration, the dual-phase strategy included validation of analytical performance before implementation. The first phase evaluated concordance between the RUO and IVD databases using parallel manual testing of isolates. Based on these results, an automated workflow was developed and validated in the second phase.

Documentation and Record Keeping

The laboratory must maintain records of all procedures, quality control results, and patient results. The World Health Organization Laboratory Quality Management System Handbook emphasizes the importance of documentation for quality assurance and traceability. Records should be retained according to regulatory requirements and institutional policy.

Biosafety in the Clinical Microbiology Laboratory

Risk Assessment and Containment

The clinical microbiology laboratory handles potentially infectious specimens and cultures. The World Health Organization Laboratory Biosafety Manual provides the framework for biosafety risk assessment and containment. Laboratories should classify organisms by risk group and implement appropriate biosafety level practices.

Standard precautions apply to all specimens. These include hand hygiene, personal protective equipment, and safe handling of sharps. Specimen processing should occur in a biological safety cabinet when aerosol generation is possible.

Decontamination and Waste Disposal

All cultures and contaminated materials require decontamination before disposal. Autoclaving is the standard method for decontaminating microbiological waste. Liquid waste should be treated with appropriate disinfectants before disposal. The laboratory should have documented procedures for waste handling and disposal.

Occupational Health

Laboratory workers should receive appropriate immunizations and health surveillance. Exposure to infectious agents should be reported and managed according to institutional policy. The Laboratory Biosafety Manual provides guidance on occupational health programs for laboratory workers.

Common Failure Patterns and Troubleshooting

Pre-Analytical Failures

Pre-analytical failures occur before the specimen reaches the laboratory. These include improper collection technique, inadequate specimen volume, delayed transport, and incorrect transport temperature. The Clinical Microbiology Newsletter article on pre-analytical conundrums addresses the challenges of specimen collection and processing guidelines.

Common pre-analytical failures include:

• Blood culture bottles filled with insufficient blood volume, reducing organism recovery
• Urine specimens refrigerated for excessive periods, allowing contaminant overgrowth
• Sputum specimens contaminated with saliva, yielding no diagnostic value
• Swabs allowed to dry during transport, killing fastidious organisms
• Specimens collected after antimicrobial therapy, reducing culture yield

Analytical Failures

Analytical failures occur during specimen processing and testing. These include media failures, incubation errors, identification errors, and susceptibility testing errors. The laboratory should investigate all analytical failures and implement corrective actions.

Common analytical failures include:

• Culture media that fails to support growth of target organisms
• Incubation conditions that do not meet organism requirements
• Identification results that do not match expected colony morphology
• Susceptibility results that conflict with known resistance mechanisms

Post-Analytical Failures

Post-analytical failures occur after testing is complete. These include reporting errors, delayed result transmission, and misinterpretation of results. The laboratory should verify results before release and communicate critical results promptly.

Common post-analytical failures include:

• Results reported to the wrong patient
• Critical results not communicated to the clinical team
• Susceptibility results reported without appropriate interpretive comments
• Results delayed beyond clinically actionable timeframes

Limitations and Interpretation Challenges

Culture-Negative Infections

Many infections are culture-negative despite appropriate specimen collection and processing. This may occur when the pathogen is fastidious, when antimicrobials were administered before collection, or when the infection is caused by an organism that does not grow on standard media. Molecular methods may detect pathogens that culture misses.

Colonization Versus Infection

The laboratory result must be interpreted in the clinical context. A positive culture may represent colonization instead of infection, particularly for specimens from sites with normal flora. The laboratory report should include appropriate comments to guide interpretation.

Small Colony Variants

Small colony variants of Staphylococcus aureus present a diagnostic challenge. There are no consensus recommendations for laboratory practices to detect, characterize, and report small colony variants, although studies are ongoing to address the potential clinical impact. Laboratories should be aware of this phenomenon and consider extended incubation when small colony variants are suspected.

Uncommon Pathogens

Increasing numbers of patients are found to have infection caused by pathogens that were either very uncommon in the past or even completely unrecognized. Accurate identification of less common Gram-negative bacilli, such as Stenotrophomonas maltophilia, Inquilinus, Achromobacter, Ralstonia, and Pandoraea species, as well as yeasts and filamentous fungi, is recommended to understand their epidemiology and clinical importance.

Professional Escalation Criteria

When to Notify the Clinical Team

The laboratory should notify the clinical team immediately for critical results. These include positive blood cultures, positive cerebrospinal fluid cultures, and detection of notifiable pathogens. The World Health Organization Laboratory Quality Management System Handbook provides guidance on critical result communication.

When to Escalate Within the Laboratory

Laboratory staff should escalate to the laboratory director or supervisor when:

• Quality control failures cannot be resolved
• Identification results are discrepant with expected findings
• Susceptibility results suggest unusual resistance patterns
• Specimen rejection rates indicate systemic collection problems
• Automation or equipment failures compromise result accuracy

When to Seek Reference Laboratory Support

Some organisms require reference laboratory testing for definitive identification or susceptibility testing. The laboratory should have established referral pathways for these cases. The mycobacteriology laboratory review notes that drug susceptibility testing of different mycobacteria may require specialized methods and reference laboratory support.

Records and Measurements for Laboratory Management

Key Performance Indicators

Laboratories should track key performance indicators to monitor quality and efficiency. These include turnaround time, contamination rates, rejection rates, and identification accuracy. The health technology assessment of total laboratory automation defined key performance indicators through literature review and expert consensus.

Turnaround Time Monitoring

Turnaround time is a key performance indicator in clinical microbiology, particularly for urine cultures, which represent a high-volume workload and directly impact antimicrobial stewardship. The comparative study of urine culture turnaround time defined turnaround time as the time from laboratory receipt to final report validation. Laboratories should monitor turnaround time by specimen type and shift to identify bottlenecks.

Productivity Measurement

Laboratory productivity can be measured as cultures per full-time equivalent staff member. The total laboratory automation study reported a 3.26-fold improvement in laboratory productivity after automation implementation. Laboratories should track productivity to justify staffing and automation investments.

Frequently Asked Questions

Why does specimen collection technique matter so much in clinical microbiology?

The accuracy of microbiological results depends to a great extent on the quality of the samples and their processing within the microbiology laboratory. The type of specimen, the appropriate time to obtain the sample, the way of sampling, the storage and transport are critical points in the diagnostic process. A poorly collected specimen may yield no growth, grow contaminants, or produce misleading results that lead to incorrect clinical decisions.

What is the difference between selective and non-selective culture media?

Non-selective media such as blood agar support the growth of a wide range of organisms. Selective media contain inhibitors that suppress normal flora while allowing target pathogens to grow. For respiratory samples from people with cystic fibrosis, non-selective and selective culture media are recommended for all types of respiratory samples to optimize detection of the range of pathogens that infect this population.

How should urine specimens be transported and stored?

Urine specimens should be processed within two hours of collection or refrigerated to prevent overgrowth of contaminating organisms. The specimen container should be sterile and leak-proof. Delayed processing allows contaminating organisms to multiply and may produce misleading colony counts.

What is the role of MALDI-TOF mass spectrometry in pathogen identification?

MALDI-TOF mass spectrometry generates a protein mass spectrum from intact bacterial cells and compares it to a reference database for species identification. The VITEK MS RUO database offers broader species coverage than the IVD database and can provide valid supplementary identification for cases where the IVD database fails. Integrated automated workflows can reduce reanalysis turnaround time by more than 75 percent.

How does total laboratory automation improve urine culture processing?

Total laboratory automation reduces setup time, total staff time, and operator-dependent variability in urine culture processing. Studies have shown reductions in setup time of 79 to 83 percent and reductions in total staff time of 77 to 78 percent. Automation also significantly reduces median turnaround time for both negative and positive cultures.

What are the limitations of syndromic testing panels?

Syndromic panels may miss low-positive samples with high cycle threshold values. The QIAstat-Dx meningitis-encephalitis evaluation found discrepant results for samples with high cycle threshold values and recommended confirmation of low-positive results with alternative methods. Syndromic panels also have defined target lists and cannot detect pathogens outside those targets.

When should a specimen be rejected by the laboratory?

Specimens should be rejected when they are improperly labeled, collected in inappropriate containers, transported in unsuitable media, or delayed beyond acceptable timeframes. The laboratory should have documented rejection criteria and should notify the clinical team for recollection. The World Health Organization Laboratory Quality Management System Handbook provides guidance on developing acceptance and rejection policies.

How does the laboratory detect carbapenemase-producing Enterobacterales?

The simplified carbapenem inactivation method provides a simple, reliable, and highly sensitive method for detecting OXA-48-producing Enterobacterales, even in cases with borderline susceptibility profiles. This method eliminates the preliminary carbapenem inactivation incubation step, simplifying the workflow and reducing turnaround time compared with the conventional method.

Related Diagnostic Guides

• Common Types of Culture Media in Microbiology: Selective, Differential, and Enriched
• How to Store and Handle Agar Plates and Culture Media for Microbiology
• Biosafety Cabinet Types and Selection Guide for Microbiology Laboratories
• Viral Isolation and Embryonated Egg Culture Methods
• Aseptic Technique in Microbiology: Essential Steps and Common Mistakes

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC).. Medicina intensiva, 2018.
• Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis.. Clinical microbiology reviews, 2024.
• Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.. Clinical microbiology reviews, 2021.
• Collection, transport and general processing of clinical specimens in Microbiology laboratory.. Enfermedades infecciosas y microbiologia clinica (English ed.), 2019.
• Consolidated clinical microbiology laboratories.. Journal of clinical microbiology, 2015.
• Automation in clinical microbiology.. Journal of clinical microbiology, 2013.
• Mycobacteriology laboratory.. Clinics in chest medicine, 1997.
• Clinical microbiology.. JPMA. The Journal of the Pakistan Medical Association, 1991.
• A multicenter evaluation of the QIAstat-Dx meningitis-encephalitis syndromic test kit as compared to the conventional diagnostic microbiology workflow.. 2024.
• A dual-phase strategy to integrate the VITEK MS RUO database into routine clinical practice: from validation of analytical performance to implementation of an automated workflow.. 2026.
• "Simplified carbapenem inactivation method (sCIM) as a reliable tool for detecting OXA-48-producing enterobacterales in clinical practice".. 2026.
• Total Laboratory Automation Versus Manual Processing in Urine Culture Inoculation and Interpretation: A Hospital Experience.. 2026.
• Diagnostic performance and cost-effectiveness of a combined rapid antimicrobial susceptibility testing (RAST) and lateral flow immunochromatographic assay-based workflow for bloodstream infections.. 2026.
• Total Laboratory Automation for Microbiology Activities: An HTA Analysis in an Italian Laboratory Setting.. 2026.
• Impact of Total Laboratory Automation on Urine Culture Turnaround Time: A Comparative Study Between Manual Workflow and WASPLab™.. 2026.
• A guide to specimen management in clinical microbiology. A Guide to Specimen Management in Clinical Microbiology, 2014.
• A GUIDE TO: Specimen Management in Clinical Microbiology, THIRD EDITION. A Guide to Specimen Management in Clinical Microbiology Third Edition, 2024.
• Specimen collection, processing, culture, and biochemical identification of acinetobacter spp.. Methods in Molecular Biology, 2019.
• If Specimen Collection and Processing Guidelines Fall, Does Anyone Hear Them? Pre-Analytical Conundrums in Clinical Microbiology. Clinical Microbiology Newsletter, 2014.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.